Immediate Impact
2 by Nobel laureates 1 from Science/Nature 85 standout
Citing Papers
Enhancing immunotherapy with tumour-responsive nanomaterials
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Works of Sajeve Thomas being referenced
Phase 1/2 study of mRNA-4359 administered alone and in combination with immune checkpoint blockade in adult participants with advanced solid tumors.
2023
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sajeve Thomas | 697 | 181 | 11 | 167 | 43 | 827 | |
| B. Vasseur | 518 | 125 | 51 | 146 | 33 | 869 | |
| Marc Ballas | 538 | 138 | 11 | 245 | 45 | 875 | |
| ML Hansmann | 341 | 242 | 66 | 145 | 31 | 874 | |
| Daoud Rahal | 587 | 209 | 3 | 89 | 46 | 975 | |
| Ayse U. Akarca | 453 | 243 | 3 | 176 | 33 | 729 | |
| Cyrus Sayehli | 483 | 239 | 5 | 215 | 36 | 804 | |
| Jeffrey Schneider | 580 | 122 | 8 | 130 | 40 | 864 | |
| Claudio Dansky Ullmann | 389 | 114 | 16 | 269 | 26 | 778 | |
| Bernies van der Hiel | 373 | 95 | 17 | 168 | 55 | 896 | |
| Sumana Devata | 334 | 260 | 3 | 142 | 51 | 744 |
All Works
Login with ORCID to disown or claim papers
Loading papers...